Cybersecurity has rapidly evolved into a crucial concern, affecting our private lives with risks such as identity theft, and at […]
Event Categorie: Open to Public
The Current State of FemTech and Upcoming Market Trends
What is FemTech, you ask? It is a sub-sector of life sciences and technology that brings the spotlight to companies […]
How to Maximize B2B Marketing Potential in the Healthcare Industry: A Guide to Effective Planning and Strategy
Join us for a live webinar on how to modernize B2B healthcare marketing. As the business needs and industry landscape […]
Maximize Your Startup’s Potential: Ensure Your Technology Solution is Prepared for Growth and Value
Healthcare technology solutions are popping up everywhere. AI, ML, and other automation solutions are more prevalent than ever. How your […]
2023 Policy Outlook for the Life Sciences
Join Marc Samuels and Lindsay Bealor Greenleaf, from ADVI Health. Two of Washington, DC’s most prominent health and life science policy […]
A Perspective from J&J Innovation: Strategic Thinking on Venture Investments Today and Into the Future?
Tamir Meiri will cover how Johnson & Johnson Venture Investments invests and supports globally to bring strategic value to companies […]
Effective Pitching for Early Stage Companies, Strategies for Success and Pitfalls to Avoid
Jared Sorin, co-leader of the Emerging Companies and Venture Capital practice group & Adam Schoen, Partner at Brown Rudnick, will […]
The Real Opportunity for Digital & Technology in Healthcare (Oliver Wyman’s Team)
Healthcare organizations from all corners are competing to leverage flexible technology infrastructure to rapidly push out offerings that meet consumer […]
Introduction to Software for Medical Devices in Early R&D Phases
Developing software for medical devices is vastly different than developing other commercial software. In this talk, we will explore how software […]
Regulatory 101: An Insider’s Perspective on Navigating the FDA Regulations Surrounding Digital Health & Devices
Interested in what makes a product salable and approvable? Interested in an insider’s view on what gets your device approved at FDA? Or how to navigate the regulations and use them to your advantage? How will recent developments to the United States Food and Drug Administration regulations impact your healthtech business? Whether you’re a CEO, entrepreneur, investor, clinician, or a professional in the general industry, join us as Neil Di Spirito gives us an insider’s perspective and breaks down what digital health and device companies should know about FDA regulations.